These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 23582991

  • 1. Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.
    Abedi F, Wickremasinghe S, Richardson AJ, Islam AF, Guymer RH, Baird PN.
    Ophthalmology; 2013 Aug; 120(8):1641-8. PubMed ID: 23582991
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacogenetic associations with long-term response to anti-vascular endothelial growth factor treatment in neovascular AMD patients.
    Park UC, Shin JY, McCarthy LC, Kim SJ, Park JH, Chung H, Yu HG.
    Mol Vis; 2014 Aug; 20():1680-94. PubMed ID: 25558172
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials.
    Maguire MG, Daniel E, Shah AR, Grunwald JE, Hagstrom SA, Avery RL, Huang J, Martin RW, Roth DB, Castellarin AA, Bakri SJ, Fine SL, Martin DF, Comparison of Age-Related Macular Degeneration Treatments Trials (CATT Research Group).
    Ophthalmology; 2013 Oct; 120(10):2035-41. PubMed ID: 23706946
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacogenetic associations with vascular endothelial growth factor inhibition in participants with neovascular age-related macular degeneration in the IVAN Study.
    Lotery AJ, Gibson J, Cree AJ, Downes SM, Harding SP, Rogers CA, Reeves BC, Ennis S, Chakravarthy U, Alternative Treatments to Inhibit VEGF in Patients with Age-Related Choroidal Neovascularisation (IVAN) Study Group.
    Ophthalmology; 2013 Dec; 120(12):2637-2643. PubMed ID: 24070809
    [Abstract] [Full Text] [Related]

  • 12. Complement factor H and high-temperature requirement A-1 genotypes and treatment response of age-related macular degeneration.
    Tsuchihashi T, Mori K, Horie-Inoue K, Gehlbach PL, Kabasawa S, Takita H, Ueyama K, Okazaki Y, Inoue S, Awata T, Katayama S, Yoneya S.
    Ophthalmology; 2011 Jan; 118(1):93-100. PubMed ID: 20678803
    [Abstract] [Full Text] [Related]

  • 13. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.
    Brantley MA, Fang AM, King JM, Tewari A, Kymes SM, Shiels A.
    Ophthalmology; 2007 Dec; 114(12):2168-73. PubMed ID: 18054635
    [Abstract] [Full Text] [Related]

  • 14. Investigation of genetic base in the treatment of age-related macular degeneration.
    Gourgouli K, Gourgouli I, Tsaousis G, Spai S, Niskopoulou M, Efthimiopoulos S, Lamnissou K.
    Int Ophthalmol; 2020 Apr; 40(4):985-997. PubMed ID: 31916060
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Factors Associated with Recurrence of Age-Related Macular Degeneration after Anti-Vascular Endothelial Growth Factor Treatment: A Retrospective Cohort Study.
    Kuroda Y, Yamashiro K, Miyake M, Yoshikawa M, Nakanishi H, Oishi A, Tamura H, Ooto S, Tsujikawa A, Yoshimura N.
    Ophthalmology; 2015 Nov; 122(11):2303-10. PubMed ID: 26271842
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Genetics in neovascular age-related macular degeneration susceptibility and treatment response to anti-VEGF intravitreal injection: A case series study.
    Chang FY, Huang CH, Yang CH, Chang JT, Yang CM, Ho TC, Hsieh YT, Lai TT, Lin CW, Lin CP, Chen YC, Lai YJ, Chen PL, Hsu JS, Chen TC.
    Clin Exp Ophthalmol; 2024 Aug; 52(6):655-664. PubMed ID: 38757252
    [Abstract] [Full Text] [Related]

  • 20. Combined effects of genetic and non-genetic risk factors affect response to ranibizumab in exudative age-related macular degeneration.
    Piermarocchi S, Miotto S, Colavito D, Leon A, Segato T.
    Acta Ophthalmol; 2015 Sep; 93(6):e451-7. PubMed ID: 25402348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.